View by Specialty

Headline News

View more

Alpha-9 Oncology doses first subject in phase 1 study for new melanoma diagnostic agent

May 05, 2024
1 min read
Save

Alpha-9 Oncology doses first subject in phase 1 study for new melanoma diagnostic agent

Alpha-9 Oncology doses first subject in phase 1 study for new melanoma diagnostic agent

The first participant has been dosed in the phase 1 study evaluating Ga-A9-3202 for locally advanced or metastatic melanoma imaging, Alpha-9 Oncology announced in a press release.

View more Headline News
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails

Resources

View more

AI in Medicine

23007715_AIinMedicineRC_OG

Artificial intelligence is a rapidly evolving field. Learn how and why it is being applied in clinical practice in multiple medical specialties.

View resource

Opioid Resource Center

200332_Opioid_RC_OG

A collection of news articles and features focused on the opioid crisis, which has been declared a public health emergency.

View resource
View more Resources
View more Meeting News
View meeting calendar

Podcasts

View more
Hematology/Oncology Oncology Overdrive
May 02, 2024
32 min listen

Innovation in Industry with Sean Bohen, MD

Hematology/Oncology Oncology Overdrive
April 18, 2024
48 min listen

Learning Leadership with Jonathan D. Licht, MD

View more Podcasts

Blogs & Columns

View more
ASTCT Update is sponsored by American Society for Transplantation and Cellular Therapy, which is dedicated to the application and success of blood and marrow transplantation and related cellular therapies. The blog provides essential updates about research advances, health policy and clinical best practices to ensure optimal patient care. ASTCT provides additional practice resources on its website.



A column for advanced practice providers to share research advances, and discuss day-to-day practice and regulatory concerns.

View more Blogs & Columns